Jefferies Group LLC Allakos Inc. Transaction History

Jefferies Group LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.55 - $111.89 $15,475 - $202,520	-1,810 Closed	0 $0
Q3 2021 Sep 21, 2023	SELL	$76.53 - $110.43 $4,438 - $6,404	-58 Reduced 3.1%	1,810 $191,000
Q3 2021 Nov 15, 2021	BUY	$76.53 - $110.43 $29,234 - $42,184	382 Added 26.75%	1,810 $192,000
Q2 2021 Aug 16, 2021	SELL	$85.37 - $114.1 $37,562 - $50,204	-440 Reduced 23.55%	1,428 $122,000
Q1 2021 Sep 21, 2023	SELL	$109.73 - $153.66 $2.32 Million - $3.25 Million	-21,132 Reduced 91.88%	1,868 $214,000
Q1 2021 May 14, 2021	SELL	$109.73 - $153.66 $2.32 Million - $3.25 Million	-21,132 Reduced 91.88%	1,868 $214,000
Q4 2020 Sep 21, 2023	BUY	$79.58 - $152.45 $1.83 Million - $3.51 Million	23,000 New	23,000 $3.22 Million
Q4 2020 Feb 16, 2021	BUY	$79.58 - $152.45 $1.78 Million - $3.41 Million	22,391 Added 3676.68%	23,000 $3.22 Million
Q3 2020 Nov 13, 2020	SELL	$66.43 - $90.99 $155,645 - $213,189	-2,343 Reduced 79.37%	609 $50,000
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $316,867 - $580,564	-7,195 Reduced 70.91%	2,952 $212,000
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $3.52 Million - $7.39 Million	-79,107 Reduced 88.63%	10,147 $451,000
Q4 2019 Feb 13, 2020	BUY	$66.49 - $137.73 $5.93 Million - $12.3 Million	89,254 New	89,254 $8.51 Million

67.3M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $21.2M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.